Werewolf Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.78

-0.08 (-9.54%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 75%

Hold 3 25%

Sell 0 0%

Price Target

Analyst Price Target +5,063.9% upside

Low Target $26.90

Average Target $40.32

High Target $53.74

Current Price $0.78

Current
$0.78

Target
$40.32

$26.90 $40.32 avg $53.74

Scenario Analysis

Bear Case

$26.90

3,345.2%

Low target

Base Case

$40.32

+5,063.9%

Avg target

Bull Case

$53.74

+6,782.7%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$2.38

-67.2% from high

52-Week Low

$0.53

+47.3% from low

Target vs 52W High

$40.32

+1,594.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.9%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+157.7%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.5%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.0%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.5%